KP Ventures invests in medical devices, health care services and health care information technology. The investment portfolio has generated eight successful exits.
Medical Devices
Health Care Services
•
AcelRx
(Drug delivery)
•
Accumetrics
(Diagnostic assay)
•
Adiana
(Permanent contraception)*
•
Arbor Surgical
(Cardiac implant)
•
Arcxis
(Molecular diagnostics)
•
Bacchus Vascular
(Vascular device)
•
Calypso
(Tumor localization)
•
CHF Solutions
(Fluid removal)
•
GeneOhm
(Molecular diagnostics)*
•
Glumetrics
(Glycemic monitoring)
•
GMD
(Cost effective medical devices)
•
NeoGuide
(Endoscopic device)
•
Predictive Biosciences
(Cancer diagnostics)
•
Proteogenix
(Maternal-fetal diagnostics)
•
Proteus
(Intelligent Medicine)
•
ValenTx
(Obesity management)
•
Valeritas
(Drug delivery)
•
Vapotherm
(Respiratory therapy)
•
Zonare
(Ultrasound equipment)
•
Avivia
(Disease management)
•
Broadlane
(Procurement services)*
•
Free & Clear
(Smoking cessation)
•
Health Dialog
(Disease care)*
•
HEARx West
(Hearing aid centers)
•
Nursefinders
(Nurse staffing)*
•
ORC
(Renal disease care)*
•
SilverLink
(Communication)
Information Technology
•
BDNA
(IT asset management)
•
Concerro
(Scheduling & bidding)
•
Emageon
(Image archiving)*
•
Healthline
(Health care search)
•
Next Web
(Broad band wireless)*
•
Radianse
(Asset tracking)
* Equity is publicly tradable or has been acquired.